Auris Medical Holding Stock Price To Sales
Auris Medical Holding fundamentals help investors to digest information that contributes to Auris Medical's financial success or failures. It also enables traders to predict the movement of Auris Stock. The fundamental analysis module provides a way to measure Auris Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auris Medical stock.
Auris |
Auris Medical Holding Company Price To Sales Analysis
Auris Medical's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Auris Medical Price To Sales | 224.60 X |
Most of Auris Medical's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auris Medical Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Auris Medical Holding has a Price To Sales of 224 times. This is much higher than that of the Healthcare sector and 128.23% higher than that of the Biotechnology industry. The price to sales for all United States stocks is notably lower than that of the firm.
Auris Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Auris Medical's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Auris Medical could also be used in its relative valuation, which is a method of valuing Auris Medical by comparing valuation metrics of similar companies.Auris Medical is currently under evaluation in price to sales category among its peers.
Auris Fundamentals
| Return On Equity | -71.91 | |||
| Return On Asset | -21.99 | |||
| Current Valuation | 32.76 M | |||
| Shares Outstanding | 12.87 M | |||
| Shares Owned By Insiders | 5.45 % | |||
| Shares Owned By Institutions | 5.34 % | |||
| Number Of Shares Shorted | 362.97 K | |||
| Price To Earning | (1.05) X | |||
| Price To Book | 2.07 X | |||
| Price To Sales | 224.60 X | |||
| Revenue | 174.47 K | |||
| Gross Profit | 174.47 K | |||
| EBITDA | (5.26 M) | |||
| Net Income | (8.2 M) | |||
| Cash And Equivalents | 11.26 M | |||
| Cash Per Share | 0.88 X | |||
| Total Debt | 523.92 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 3.83 X | |||
| Book Value Per Share | 1.47 X | |||
| Cash Flow From Operations | (4.84 M) | |||
| Short Ratio | 0.15 X | |||
| Earnings Per Share | (1.49) X | |||
| Beta | 1.37 | |||
| Market Capitalization | 39.19 M | |||
| Total Asset | 41 M | |||
| Retained Earnings | (164.84 M) | |||
| Working Capital | 31 M | |||
| Current Asset | 39 M | |||
| Current Liabilities | 8 M | |||
| Z Score | 38.8 |
Thematic Opportunities
Explore Investment Opportunities
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Auris Stock
If you are still planning to invest in Auris Medical Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Auris Medical's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |